IPOs
Israeli biomedical firm Foamix is moving ahead with its New York IPO, but has greatly reduced its expectations, dropping it’s per share asking price...
Hi, what are you looking for?
Israeli biomedical firm Foamix is moving ahead with its New York IPO, but has greatly reduced its expectations, dropping it’s per share asking price...
– Foamix integrates its foam technology with existing drugs used to treat skin diseases like acne. – Foamix, which develops foam-based drugs, today revised...
Israeli startup Foamix Ltd, which makes foams used for drug delivery and has recently developed a new treatment for acne, has announced plans for...
– The advanced cell therapy for chronic wound therapy company pricing of the shares at $10 was well below the $13-15 range that the...
– The clinical stage biotech company is selling 5.4 million ordinary shares at $12 each. Clinical-stage biotech company VBL Therapeutics has announced the pricing...
– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday, VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus...
– Oppenheimer: Wix is one of the few companies successfully leveraging a model. – Wix.com Ltd. (Nasdaq: WIX), whose share price has climbed 80% since it...